NITIN THAPAR: Open Payments
NPI 1780927483 · ORLAND PARK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$44,447 in 143 payments from 22 companies in 2025. Trend: 2023 $59,135 · 2024 $18,421 · 2025 $44,447
Speaker / faculty: $35,655Travel & lodging: $5,275Food & beverage: $3,415Education: $101
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 48 | $31,759 |
| Vanda Pharmaceuticals Inc. | 31 | $11,029 |
| Axsome Therapeutics, Inc. | 8 | $292 |
| Teva Pharmaceuticals USA, Inc. | 7 | $236 |
| E.R. Squibb & Sons, L.L.C. | 6 | $139 |
| Tris Pharma Inc | 6 | $134 |
| Otsuka America Pharmaceutical, Inc. | 5 | $128 |
| Janssen Pharmaceuticals, Inc | 4 | $104 |
| Lundbeck LLC | 4 | $93 |
| Neurocrine BioSciences, Inc. | 3 | $89 |
Products named: VRAYLAR, FANAPT, Auvelity, REXULTI, COBENFY, Dyanavel XR, AUSTEDO XR, INGREZZA.
Industry payments across IL — which companies pay providers there.
